Dermal sensitization, safety, and tolerability of triple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel from three clinical trials.
Zoe Diana DraelosEmil A TanghettiLeon H KircikNeal BhatiaJoshua A ZeichnerJeffrey L SugarmanLinda Stein GoldPublished in: The Journal of dermatological treatment (2023)
The results from these three studies show that the triple-combination IDP-126 had a positive safety profile and was well tolerated in healthy participants and those with moderate-to-severe acne.